Resistance to phagocytosis by pathogenic microorganisms may be due to a variety of mechanisms depending on the species. For example, bacteria may produce substances toxic for leucocytes such as the "leucocidins" produced by staphylococci and hemolytic streptococci. Another mechanism suggested by Hale and Smith (1) may operate in the case of pathogenic staphylococci; these bacteria produce an enzyme, coagulase, which acting in concert with a serum factor catalyzes the conversion of fibrinogen to fibrin. According to Hale and Smith, the fibrin meshwork so formed, impedes the activity of the leucocytes, and furthermore, fibrin, intimately deposited about the staphylococci, in some way interferes with their ingestion.
Rogers and Tompsett (2), using human leucocytes, confirmed the observation that coagulaseproducing staphylococci are less well ingested than coagulase negative strains, but believe that the observed difference was not of sufficient magnitude to be a factor of major importance in explaining the difference in pathogenicity between the two species.
The production of capsules by certain bacterial species can be correlated with pathogenicity. Specific anticapsular serum renders the encapsulated organism relatively defenseless to leucocyte activity. Wood, Smith, and Watson (3, 4) have shown, however, that encapsulated pathogens may be ingested in the absence of specific antibody both in vitro and in vivo provided the leucocytes can push the organisms against a nonyielding surface. A fibrin meshwork such as occurs in blood clots or inflammatory exudates offers an excellent matrix 1 This study was for phagocytosis in the absence of antibody (5) . The validity of "surface phagocytosis" is unquestioned, but its quantitative significance in vivo has not been defined.
The observed difference in the effect of fibrin on the ingestion of coagulase positive staphylococci and encapsulated pneumococci suggests that enzymatic therapy designed to reduce the amount of fibrin in inflammatory lesions (6, 7) may increase or diminish natural phagocytosis depending on the microorganisms involved.
An attempt has been made in the present study to confirm the observations of Hale and Smith (1) on the influence of coagulase production by staphylococci on phagocytosis and to determine the effect of streptokinase on this process. In addition, surface phagocytosis of type II encapsulated pneumococci has been studied quantitatively and the effect of streptokinase on it has been evaluated.
METHODS
The influence of coagulase on the ingestion of staphylococci by human leucocytes was determined by (a) Table I records mean ingestion of (C+) and (C-) staphylococci by neutrophils in four different blood preparations: blood plus heparin, blood plus streptokinase, defibrinated blood, and defibrinated blood plus streptokinase. Mean ingestion of all coagulase positive strains (I, II, III, and IV) has been recorded in each preparation because this was not significantly different with individual strains.
In comparing neutrophil ingestion, it may be important to keep the ratio of bacteria to phagocytes constant (8, 9) . In the present experiments the bacterial suspensions used were always adjusted to the same turbidity and the neutrophil count per cubic millimeter determined for each blood preparation. The over-all ratio averaged 1 neutrophil to 50 bacteria. Since bacteria were always present in considerable excess, the differences in ratio of bacteria to neutrophils in different experiments is probably not an important factor. In any event, under the conditions of our experiments, the degree of phagocytosis appeared to be independent of the neutrophil count. A similar observation was recorded by another group of investigators (10) .
Ingestion of (C-) staphylococci. There was no significant difference in the ingestion of (C-) staphylococci by neutrophils in heparinized blood, streptokinase-treated blood, blood defibrinated with glass beads, or in the latter containing streptokinase. Therefore, it may be concluded that in these experiments, heparin and streptokinase did not affect phagocytosis; this agrees with the findings of others (11) (12) (13) . The data also show that the removal of fibrinogen with glass beads does not influence ingestion.
Ingestion of (C+) staphylococci. There was a significant reduction in the mean ingestion of (C+) staphylococci by neutrophils in heparinized blood compared with their mean ingestion by neutrophils in all the other blood preparations. However, significantly fewer (C+) staphylococci were ingested by leucocytes in streptokinase-treated blood compared with leucocytes in blood defibrinated by glass beads. The addition of streptokinase to the latter did not significantly alter the phagocytic index.
These data showed that coagulase-producing staphylococci were less readily ingested in the presence of fibrin, which agrees with the findings of Hale and Smith (1) and Rogers and Tompsett (2) . But under the conditions of the present experiments considerably more (C+) staphylococci were ingested in the presence of fibrin than reported by the above authors.
The diminished ingestion of (C+) staphylococci in streptokinase-treated blood was an unexpected finding. This was probably not due to a direct effect of streptokinase on leucocytes because a comparable amount of the enzyme did not affect the ingestion of either (C-) or (C+) staphylococci in the absence of fibrinogen. It might have been due to incomplete removal of fibrinogen by streptokinase, although sufficient enzyme was added to lyse completely the clot which formed spontaneously after drawing the blood; moreover, there was no gross or microscopic evidence of fibrin in the streptokinase-treated blood after incubation for one hour with (C+) staphylococci. However, special fibrin stains were not used in these studies.
Ingestion of (C+) staphylococci compared with ingestion of (C-) staphylococci. The mean ingestion of (C-) staphylococci was greater than that of (C+) staphylococci in heparinized blood. This difference was significant. In contrast phagocytosis of (C+) staphylococci was greater than that of (C-) staphylococci both in blood defibrinated by glass beads and in defibrinated blood to which streptokinase had been added. There was no significant difference in the mean ingestion of the two species of staphylococci in the streptokinase-treated blood. It is possible that the latter finding was due to incomplete removal of fibrinogen which resulted in decreased ingestion of (C+) strains as discussed above.
Petri dish technique
The Petri dish technique was devised for two reasons; first, to attempt to record quantitatively the phagocytosis of (C+) staphylococci exposed Ingestion of (C-) staphylococci. There was no significant difference in the ingestion of (C-) staphylococci by neutrophils in any of the blood preparations, showing that in these experiments, thrombin, heparin, streptokinase, or defibrination with glass beads did not affect phagocytosis.
Ingestion of (C+) staphylococci. The mean ingestion of (C+) staphylococci by neutrophils was greatest in defibrinated blood, somewhat smaller in heparinized blood, and least in streptokinase-treated blood. These differences are statistically significant. There is no obvious explanation for the relatively low mean ingestion in streptokinase-treated blood unless it was the presence of an additional 1,200 units of streptokinase in this preparation. But, as reported above, under identical conditions no significant difference was found in the ingestion of (C-) staphylococci. The mean ingestion of (C+) staphylococci by neutrophils in heparinized blood was higher in Petri dishes than in roller tubes. This was probably due to the addition of streptokinase to the former at the end of one hour's incubation; fibrinolysis The observations reported in the present paper Ingestion of (C+) staphylococci compared with confirm findings of others on the apparent influthat of (C-) staphylococci. Significantly more ence of fibrin on the phagocytosis of staphylococci (C+) staphylococci were ingested than (C-) and of pneumococci (1, 2, 5 ). It appears to play staphylococci in all blood preparations. Because a passive role and influences ingestion differently fibrin was not a constant factor in determining depending on the microorganism studied. Fibrin phagocytosis of staphylococci as measured in the probably impedes neutrophil mobility and so limPetri dish technique (owing to fibrinolysis during its optimal contact between leucocytes and microthe second hour of the experiment), the observed organisms. But actual ingestion of (C+) staphydifferences are most likely the result of chemow lococci may be hindered by the interposition of a taxis.
fibrin coat between the staphylococcus and the Ingestion of type II pneumococci. There was a neutrophil. Encapsulated pneumococci are more marked increase in the ingestion of encapsulated readily ingested in a fibrin clot which has been type II pneuniococci in the presence of fibrin produced by thrombin activity. Here the fibrin strands (blood plus heparin), compared with in-strands serve as a barrier against which the microgestion of the microorganisms in streptokinase-organisms can be pushed to facilitate ingestion. treated blood or defibrinated blood. The addition There is another possible explanation for the difof specific antibody to the heparinized blood mix-fering effect of fibrin on the ingestion of (C+) tures resulted in a further increase in encapsulated staphylococci and encapsulated pneumococci.
pneumococcal ingestion. The latter increase was Data presented in this study demonstrated that a relatively small but under the experimental condi-significant reduction in phagocytosis of (C+) tions statistically significant. The addition of staphylococci occurred in the presence of fibrin, specific antibody to the streptokinase-treated or but failed to show that their ingestion was imposdefibrinated blood preparations also resulted in a sible under these conditions. Neutrophils may be greatly increased ingestion of encapsulated pneu-seen to move among fibrin strands in warm stage mococci, compared with their ingestion in the ab-preparations so it is possible that some ingestion of sence of antibody. Here too, mean ingestion was (C+) staphylococci occurs in fibrin clots. If this somewhat greater than that which occurred in the is true, the apparent paradox in the role of fibrin presence of fibrin only.
on the ingestion of staphylococci and pneumococci Ingestion of rough pneumococci. Statistia Ingestio ofr n. Scould be explained by the fact that both microoranalysis of the data on the ingestion of rough pneu-ganisms are ingested to some extent in the presmococci (variant of the encapsulated type II pneumococcus) in the three blood preparations re-ence of fibrin; but a limiting effect can only be vealed no clear-cut difference. However, the shown with the staphylococcus. Hale and Smith rough strain was ingested in much greater num- (1) showed that as the exposure time of microbers than the encapsulated strain to which type organism to leucocytes in plasma was increased, specific antibody had been added.
(C+) stphylococcal ingestion was decreased.
Ingestion of (C+) staphylococci compared With They interpret this as evidence that ingestion of that of encapsulated pneumococci. The mean in-(C+) microorganisms occurs before fibrin forms gestion of (C+) staphylococci was much greater due to coagulase activity, but this-experiment is than that of encapsulated pneumococci, especially not inconsistent with the above hypothesis.
The formation of fibrin may not be the only factor which influences the -ingestion of (C+) staphylococci by neutrophils in plasma. Several investigators (14) (15) (16) have reported that (C+) staphylococci clump rapidly when suspended in plasma. This is apparently related to the presence of fibrinogen and usually does not occur in serum; clumping also occurs in fibrinogen solutions (16 The influence of streptokinase on the phagocytosis of (C+) staphylococci is not entirely clear. The data show that it does not affect the ingestion of coagulase negative staphylococci, rough pneumococci, or opsonized type II encapsulated pneumococci; but when added to plasma, streptokinase appears to hinder the ingestion of (C+) staphylococci, even though such blood will not clot. The addition of an equal amount of streptokinase to blood defibrinated with glass beads does not influence phagocytosis of the same organisms. All these data suggest that streptokinase does not affect neutrophil activity per se. A possible explanation is that the quantity of streptokinase used was insufficient to remove all the fibrinogen from the plasma and so coagulase still promoted the coating of individual staphylococci by fibrin. However, we found no gross or microscopic evidence of fibrin formation following coagulase activity in the preparations.
The observations reported in this paper suggest that the removal of fibrin by streptokinase may be of some value in the local therapy of coagulase positive staphylococcal infection, because mean ingestion was improved over that occurring in heparinized blood. But in pneumococcal infection, it seems likely that streptokinase therapy would impede phagocytosis of encapsulated pneumococci if used to remove fibrin before the appearance of specific antibody. SUMMARY 1. The production of coagulase by staphylococci diminishes the ingestion of these organisms by neutrophil polymorphonuclear leucocytes.
2. The phenomenon of "surface phagocytosis" of encapsulated pneumococci has been confirmed and defined quantitatively. Mean ingestion by this mechanism was about 65 per cent of that occurring in the presence of specific antibody.
3. Data are presented showing that the removal of fibrin by streptokinase will prevent significant ingestion of encapsulated pneumococci if specific antibody is absent.
